Prescription drug · UNAPPROVED DRUG OTHER
Phenobarbital NDC 62135-410
Phenobarbital 30 mg/1 · Tablet · Oral · Chartwell RX, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62135-410-05 | 62135041005 | 500 TABLET in 1 BOTTLE (62135-410-05)Marketed from Sep 1, 2022 | |
| 62135-410-60 | 62135041060 | 60 TABLET in 1 BOTTLE (62135-410-60)Marketed from Sep 1, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Phenobarbital
- Generic name (nonproprietary)
- phenobarbital
- Active ingredients
- Phenobarbital — 30 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Chartwell RX, LLC
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Identifiers
- Product ID 62135-410_45ae5eb0-ee63-8c29-e063-6294a90a2e42SPL ID 45ae5eb0-ee63-8c29-e063-6294a90a2e42SPL set ID fa83619c-81b9-4e69-b36e-46e396bb7286RxCUI 198083, 198086, 198089, 199164, 199167, 199168, 312357, 312362UNII YQE403BP4DUPC 0362135410056, 0362135409050, 0362135412050, 0362135406608, 0362135407605, 0362135405120, 0362135409128, 0362135411053, 0362135410605, 0362135412906, 0362135411602, 0362135408305
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N462135041005followed by a unit qualifier and the quantityPackage 62135-0410-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Sedative Anticonvulsant – For the treatment of generalized and partial seizures.
Excerpt only. Read the full label for complete information.